Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactated Ringer's and Dextrose is a sterile, single-dose intravenous crystalloid solution containing sodium chloride, calcium chloride, sodium lactate, potassium chloride, and dextrose monohydrate. It is used for parenteral replacement of extracellular fluid and electrolytes, provides modest carbohydrate calories through dextrose, and has an alkalinizing effect because lactate is metabolized with consumption of hydrogen ions. The product is indicated in adults and pediatric patients as a source of water, electrolytes, and calories or as an alkalinizing agent. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6acc9f96-7088-45a7-b48f-1a861e3467ab))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactated ringer's and dextrose.